Page 118 - 2019_11 Resto del Mondo-web

C. Di Genua et al. References
1. Sykes SM, Kokkaliaris KD, Milsom MD, Levine RL, Majeti R. Clonal Evolution of Preleukemic hematopoietic stem cells in acute myeloid leukemia. Exp Hematol. 2015; 43(12):989-992.
2. Estey E, Dohner H. Acute myeloid leukaemia. Lancet. 2006;368(9550):1894- 1907.
3. Cancer Genome Atlas Research N. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013; 368(22):2059-2074.
4. Reckzeh K, Bereshchenko O, Mead A, et al. Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model. Leukemia. 2012;26(7):1527- 1536.
5. Shih AH, Jiang Y, Meydan C, et al. Mutational cooperativity linked to combina- torial epigenetic gain of function in acute myeloid leukemia. Cancer Cell. 2015; 27(4):502-515.
6. Yang L, Rodriguez B, Mayle A, et al. DNMT3A Loss Drives Enhancer Hypomethylation in FLT3-ITD-Associated Leukemias. Cancer Cell. 2016;29(6):922-934.
7. Papaemmanuil E, Gerstung M, Bullinger L, et al. Genomic Classification and Prognosis in Acute Myeloid Leukemia. N Engl J Med. 2016;374(23):2209-2221.
8. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3(7):730-737.
9. Miyamoto T, Weissman IL, Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci U S A. 2000;97(13):7521-7526.
10. Jan M, Snyder TM, Corces-Zimmerman MR, et al. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci Transl Med. 2012;4(149):149ra118.
11. Shlush LI, Zandi S, Mitchell A, et al. Identification of pre-leukaemic haematopoi- etic stem cells in acute leukaemia. Nature. 2014;506(7488):328-333.
12. Corces-Zimmerman MR, Hong WJ, Weissman IL, Medeiros BC, Majeti R. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc Natl Acad Sci U S A. 2014;111(7):2548-2553.
13. Dohner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424-447.
14. Miyamoto T, Nagafuji K, Akashi K, et al. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long- term remission patients with t(8;21) acute myelogenous leukemia. Blood. 1996;87(11):4789-4796.
15. Krauth MT, Eder C, Alpermann T, et al. High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1- RUNX1T1: frequency and impact on clinical outcome. Leukemia. 2014;28(7):1449-1458.
16. Higuchi M, O'Brien D, Kumaravelu P, Lenny N, Yeoh EJ, Downing JR. Expression of a con- ditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell. 2002;1(1):63-74.
17. Guryanova OA, Shank K, Spitzer B, et al. DNMT3A mutations promote anthracycline
resistance in acute myeloid leukemia via impaired nucleosome remodeling. Nat Med. 2016;22(12):1488-1495.
18. Braun BS, Tuveson DA, Kong N, et al. Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder. Proc Natl Acad Sci U S A. 2004;101(2):597-602.
19. Chan IT, Kutok JL, Williams IR, et al. Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. J Clin Invest. 2004;113(4):528-538.
20. Sabnis AJ, Cheung LS, Dail M, et al. Oncogenic Kras initiates leukemia in hematopoietic stem cells. PLoS Biol. 2009;7(3):e59.
21. Chu SH, Heiser D, Li L, et al. FLT3-ITD knockin impairs hematopoietic stem cell qui- escence/homeostasis, leading to myeloprolif- erative neoplasm. Cell Stem Cell. 2012;11(3):346-358.
22. Chan G, Kalaitzidis D, Usenko T, et al. Leukemogenic Ptpn11 causes fatal myelopro- liferative disorder via cell-autonomous effects on multiple stages of hematopoiesis. Blood. 2009;113(18):4414-4424.
23. Li Q, Bohin N, Wen T, et al. Oncogenic Nras has bimodal effects on stem cells that sustain- ably increase competitiveness. Nature. 2013;504(7478):143-147.
24. Mead AJ, Neo WH, Barkas N, et al. Niche- mediated depletion of the normal hematopoietic stem cell reservoir by Flt3- ITD-induced myeloproliferation. J Exp Med. 2017;214(7):2005-2021.
25. Jackson EL, Willis N, Mercer K, et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 2001;15(24):3243-3248.
26. Kuhn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science. 1995;269(5229):1427-1429.
and elevated transcriptional output of the pathway. Proc Natl Acad Sci U S A. 2009; 106(11):4519-4524.
35. Carnevalli LS, Scognamiglio R, Cabezas- Wallscheid N, et al. Improved HSC reconsti- tution and protection from inflammatory stress and chemotherapy in mice lacking granzyme B. J Exp Med. 2014;211(5):769-779.
36. Aguilo JI, Anel A, Catalan E, et al. Granzyme B of cytotoxic T cells induces extramitochon- drial reactive oxygen species production via caspase-dependent NADPH oxidase activa- tion. Immunol Cell Biol. 2010;88(5):545-554.
37. Taniguchi Ishikawa E, Gonzalez-Nieto D, Ghiaur G, et al. Connexin-43 prevents hematopoietic stem cell senescence through transfer of reactive oxygen species to bone marrow stromal cells. Proc Natl Acad Sci U S A. 2012;109(23):9071-9076.
38. Ito K, Ito K. Hematopoietic stem cell fate through metabolic control. Exp Hematol. 2018;64:1-11.
39. Tonks A, Pearn L, Musson M, et al. Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human pro- genitor cells and in acute myeloid leukaemia. Leukemia. 2007;21(12):2495-2505.
40. Zhao S, Zhang Y, Sha K, et al. KRAS (G12D) cooperates with AML1/ETO to initiate a mouse model mimicking human acute myeloid leukemia. Cell Physiol Biochem. 2014;33(1):78-87.
41. Chou FS, Wunderlich M, Griesinger A, Mulloy JC. N-Ras(G12D) induces features of stepwise transformation in preleukemic human umbilical cord blood cultures express- ing the AML1-ETO fusion gene. Blood. 2011;117(7):2237-2240.
42. Adolfsson J, Borge OJ, Bryder D, et al. Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self- renewal capacity. Immunity. 2001;15(4):659-
27. Bereshchenko O, Mancini E, Moore S, et al. 669.
Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPalpha mutant AML. Cancer Cell. 2009;16(5):390- 400.
28. Pronk CJ, Rossi DJ, Mansson R, et al. Elucidation of the phenotypic, functional, and molecular topography of a myeloery- throid progenitor cell hierarchy. Cell Stem Cell. 2007;1(4):428-442.
29. Velasco-Hernandez T, Sawen P, Bryder D, Cammenga J. Potential pitfalls of the Mx1- Cre system: implications for experimental modeling of normal and malignant hematopoiesis. Stem Cell Reports. 2016; 7(1):11-18.
30. Ichikawa M, Asai T, Saito T, et al. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat Med. 2004; 10(3):299-304.
31. Growney JD, Shigematsu H, Li Z, et al. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative pheno- type. Blood. 2005;106(2):494-504.
32. Cai X, Gaudet JJ, Mangan JK, et al. Runx1 loss minimally impacts long-term hematopoietic stem cells. PloS One. 2011;6(12):e28430.
33. Drissen R, Buza-Vidas N, Woll P, et al. Distinct myeloid progenitor-differentiation pathways identified through single-cell RNA sequencing. Nat Immunol. 2016;17(6):666- 676.
34. Pratilas CA, Taylor BS, Ye Q, et al. (V600E)BRAF is associated with disabled feedback inhibition of RAF-MEK signaling
43. Chang YI, You X, Kong G, et al. Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogen- esis. Leukemia. 2015;29(9):1847-1856.
44. Xue L, Pulikkan JA, Valk PJ, Castilla LH. NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbfbeta- SMMHC via activation of MEK/ERK axis. Blood. 2014;124(3):426-436.
45. Lewandowski D, Barroca V, Duconge F, et al. In vivo cellular imaging pinpoints the role of reactive oxygen species in the early steps of adult hematopoietic reconstitution. Blood. 2010;115(3):443-452.
46. El-Hadya SBM, Almasryc E, ElHefneyb AM. Detection of Cx43 and P27 in acute myeloid leukemia patients with t(8;21). Egypt J Haematol. 2012;37(2):1110-1067.
47. Ng SW, Mitchell A, Kennedy JA, et al. A 17- gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540(7633):433-437.
48. Krivtsov AV, Twomey D, Feng Z, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature. 2006;442(7104):818-822.
49. Kirstetter P, Schuster MB, Bereshchenko O, et al. Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expres- sion signature of committed myeloid leukemia-initiating cells. Cancer Cell. 2008;13(4):299-310.
50. Grove CS, Vassiliou GS. Acute myeloid leukaemia: a paradigm for the clonal evolu- tion of cancer? Dis Model Mech. 2014;7(8):941-951.
2224
haematologica | 2019; 104(11)